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Two local isolates of Eimeria tenella gametocytes against coccidiosis were 
immunologically evaluated in chickens. Cell mediated immune response was 
detected by modified splenic cell migration inhibition assay (MSCMIA) and data 
were expressed in terms of per cent migration index. No significant difference in per 
cent migration index was detected for the chickens immunized either with Vaccine-I 
(local isolate-I) or with Vaccine-II (local isolate-II); however per cent migration 
index was comparatively lower in chickens immunized with Vaccine-II as 
compared to Vaccine-I; indicating a somewhat higher cell mediated immune (CMI) 
response. Humoral immune response was monitored by ELISA in vaccinated and 
control chickens. Significantly elevated (P<0.05) antibody titer (IgG) in chickens 
immunized with Vaccine-II as compared to Vaccine-I was detected. Significantly 
higher protection (67%) in chickens immunized with Vaccine-II followed by 
vaccine-I (49%) was recorded. Further, oocyst count was significantly lower 
(P<0.05) in chickens immunized with Vaccine-II as compared to those immunized 
with Vaccine-I. It was concluded that vaccinal strain (Vaccine-II) contained 
additional protein of high molecular weight (49.23 kDa) in its gametocytes provided 
cross protection and can be used to prepare commercial vaccine  against coccidiosis 
in poultry. 
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INTRODUCTION 
 
Coccidiosis remains one of the major menaces for 
poultry industry throughout the world (Hafez, 2011). The 
disease is traditionally controlled by the use of chemopro- 
phylactic measures including anti-coccidials in feed that 
inhibit the developmental stages of Eimeria (Calnek et al., 
1997). No doubt, the continuous use of anti-coccidials has 
proved to be quite helpful in controlling the disease in 
commercial poultry production systems (Allen and 
Fetterer, 2002). But there could be several shortcomings 
related to this strategy. These include cost, variable 
withdrawal times, emergence of drugs resistant strains 
(Dalloul and Lillehoj, 2005) and the possible constraints 
by the regulatory authorities on medication of feed in 
animals (McEvoy, 2001) that are used for human 
consumption. Thus, vaccination of birds seems to be a 
safer and promising tool to control avian coccidiosis.  
Vaccines available in market such as Immucox, 
Coccivac, Livacox, Paracox and Viracox (Chapman et al., 
2002; Williams, 2002) contained live virulent or 
attenuated lines of Eimerian parasites (Bedrnik et al., 
1995) except CoxAbic that contained native gametocytes 
(Wallach, 2002). Many of the commercial vaccines are 
being used in different parts of the world with variable 
results due to the fact that coccidial strains from different 
geographical regions exhibit different antigenicity (Martin 
et al., 1997). Laboratory and field trials conducted 
previously by using gametocyte vaccines from local 
isolate of Eimeria tenella were found to be effective in 
mixed spp. coccidial infection in chickens (Hafeez et al., 
2006; Anwar et al., 2008). Present study reports the 
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immunological evaluation of the two isolates of Eimeria 
against coccidiosis in chickens.  
 
MATERIALS AND METHODS 
 
Parasite Stages: Sporulated oocysts of 2 local isolates of 
E. tenella maintained in Immunoparasitology Laboratory, 
Department of Parasitology, University of Agriculture, 
Faisalabad-Pakistan were processed for excystation to get 
sporozoites following the methodology of Speer et al. 
(1973). The sporozoites were washed twice with 
phosphate buffered saline (PBS) and their concentration 
was adjusted to 1.8x10
3- 2x10
3 per 100 µL and stored at 
4°C until use.  
Nine days old chicken embryos (2 batches of 200 each) 
were purchased from a hatchery at Faisalabad, Pakistan and 
maintained in an incubator at 39°C with 70% humidity. The 
viability of the embryos was confirmed by candling. On day 
12
th of age, 100 µl from sporozoites suspensions of each 
isolate, containing penicillin (2000 IU) and streptomycin 
(0.05mg), was inoculated into the embryos through chorio-
allantoic membranes (2 batches). The embryos were 
maintained for 5-7 days at 39°C temperatures and 70% 
relative humidity. On day 5
th-7
th post-inoculation, 
gametocytes were harvested and washed according to the 
methodology described by Hafeez et al. (2006). 
 
Vaccine formulation: Gametocyte antigens of both the 
isolates were prepared separately following the 
methodology described previously (Hafeez et al., 2006). 
In brief, gametocytes were homogenized by sonication 
(1x3 minutes; Nissei, Model US 330, Japan) at 4-8
oC. 
Supernatant obtained after centrifugation (9500 g/15 
minutes) was used as antigen and their protein contents 
measured by using the methodology of Bradford (1976) 
were adjusted to 500µg/0.2ml with PBS. Each vaccine 
dose contained 500 µg proteins. Both the vaccines were 
designated as Vaccine-I and Vaccine-II, respectively. 
 
Experiment: A total of 180 chicks (Hubbard) procured 
from a hatchery at Faisalabad, Pakistan were reared under 
standard management conditions (specific pathogen free 
environment) at Experimental shed, Department of 
Parasitology, University of Agriculture, Faisalabad-
Pakistan. On day 5
th of age, chickens were separated into 
three equal groups A, B and C (n= 60 in each group). On 
day 10
th of age, chickens in groups A and B were 
administered with experimental gametocyte vaccines 
(Vaccine-I and Vaccine- II, respectively) with the help of 
an oral gavage; whereas group C served as control was 
administered with PBS. Chickens were confirmed for 
their coccidia free status by coprological examination.  
On day 14
th post vaccination (PV), blood and spleens 
were collected from fifteen chickens in each group. On 
day 15
th PV, the remaining chickens of groups A and B 
(n=45) were administered with the booster dose of the 
respective vaccine and those in group C with PBS. On day 
21
st PV (primary dose), again blood and spleen samples 
were collected from fifteen chickens in each group for 
detection of cellular and humoral immune responses.  
Spleens were used immediately just after collection to 
demonstrate the cell mediated immunity by splenic cell 
migration inhibition assay (Akhtar et al., 1999). On the 
other hand, to detect the humoral immunity, serum was 
collected from blood samples and subjected to ELISA 
(Hafeez et al., 2006).  
On day 21
st, the remaining chicken in each group 
(n=30) were orally challenged with 6.5 X 10
4 sporulated 
oocysts of mixed species of Eimeria [local isolates; 
mainly E. maxima, E. tenella and E. acervulina (1:1:1)]. 
Fecal examination was performed on daily basis up to day 
10
th post challenge and oocysts per gram of droppings 
(OPG) were calculated by McMaster counting technique. 
Clinical symptoms and mortality during the experiment in 
each group was monitored up to 10 days post challenge. 
Per cent protection and mortality was also calculated in 
each group post challenge. Dead and survived chickens in 
all the groups were monitored for lesion scoring upto day 
10
th post challenge (Johnson and Reid, 1970).  
 
RESULTS AND DISCUSSION 
 
Numerous commercial vaccines are being used in 
many parts of the world to control coccidiosis in chickens. 
A generalized limitation regarding their use in broiler and 
high roster birds is marked reduction in weight gain and 
feed conversion ratios (FCR) as compared to birds 
receiving some anticoccidial agents in feed as a 
prophylactic measures (Shapiro, 2001; Crouch et al., 
2003). In addition, there is a threat of the introduction of 
unwanted Eimeria (E.) species into the environment due 
to variant antigenicity of coccidial strains in different 
constituencies of the world (Martin et al., 1997). Further, 
some strains of Eimeria showed immunological variation 
(Lee, 1993) and such strains could impair the efficacy of 
vaccines. In such circumstances, vaccines prepared from 
local isolates of parasite have been reported to give 
promising results (Hafeez et al., 2006; Anwar et al., 
2008). This study reports the immunological evaluation of 
the two isolates of Eimeria in terms of cellular, humoral 
and challenge responses.  
In the present study, CMI in vaccinated and control 
chicken, was demonstrated by MSCMIA; and the results 
were expressed in terms of per cent migration index.  In 
vaccinated chickens, sensitized splenic T-cells become re-
sensitized with the test antigen in vitro and therefore the 
migration of T-cells inhibited more with antigen. It can be 
speculated that these sensitized splenic Tdth cells release 
lymphokines including interleukins (IL-1, IL-2, IL-4) and 
other cytokines such as migration inhibition factor, which 
inhibit the migration (Oldham, 2009). This reflects that 
the test antigen used for vaccination activated the T-cells 
to initiate the cellular immune response. In majority of the 
parasitic infections, protection can be obtained 
experimentally in normal chickens by the transfer of 
splenocytes, especially the T-cells, from the immunized 
birds. This is due to the fact that T-cells secrete IL-10, 
which hinders the release and activity of the INF-γ needed 
to activate macrophages and rule out the parasitic 
infection, possibly by the enhanced production of 
cytotoxic T-cells and NK cells (Roitt et al., 1998). There 
was no significant difference (p>0.05) in per cent 
migration index in the chickens immunized either with 
Vaccine-I or with Vaccine-II; however it was 
comparatively lower in chickens immunized with 
Vaccine-II as compared to Vaccine-I (Table 1); indicated Pak Vet J, 2012, 32(1): 77-80. 
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to somewhat higher CMI response. Moreover, significant 
difference in CMI response in terms of per cent migration 
index was recorded on days 14
th and 21
st post vaccination, 
irrespective of the vaccine administered. Further, 
significantly lower (P<0.05) migration index in vaccinated 
groups as compared to control; indicated the higher CMI 
response in vaccinated chickens as compared to the control.  
 
Table 1: Migration distance with and without antigen on days 14
th and 
21
st post vaccination 
Migration Distance (µm±SE)  Days Post 
Vacci-
nation 
Vaccine 
With 
Antigen 
Without 
Antigen 
Migration 
Index (%) 
14 Vaccine-I  24.9±1.18
b 32.5±1.36
b 76 
 Vaccine-II  26.7±1.60
b 36.2±1.07
b 73 
 Control  36.0±1.27
a 38.3±1.33
a 93 
21 Vaccine-I  49.8±2.25
b 62.0±1.87
b 80 
  Vaccine-II 46.2±1.27
b 59.0±2.24
b 78 
  Control 70.1±2.87
a 74.8±2.80
a 93 
Means having different letters in a column are statistically significant 
(P<0.05). 
 
Humoral response in vaccinated and control chickens 
were monitored through ELISA and results were 
demonstrated in terms of optical density (OD) values. 
ELISA results showed a significantly higher (P<0.05) 
antibody titer (IgG) in chickens immunized with Vaccine-
II as compared to Vaccine-I. Further, irrespective of 
vaccine, the antibody titer was significantly higher 
(P<0.05) in vaccinated as compared to control chickens 
(Table 2). The role of antibodies in providing protective 
immunity against coccidiosis is controversial. It has been 
assumed that antibodies probably develop in parallel with 
the cellular immunity (Gilbert et al., 1988). In the preset 
study, vaccines contained gametocyte proteins that are 
present in the wall forming bodies of the macro-gametes 
(WFBs) and play a pivotal role in the development of 
Eimerian parasites (Mello et al., 2006).  
 
Table 2: ELISA results on days 14
th and 21
st Post Vaccination (PV) 
14
th day pv  21
st day PV  Vaccine 
OD (Mean)  SD (±)  OD (Mean)  SD (±) 
Vaccine-I 0.189
aB 0.041 0.279
aA 0.049 
Vaccine-II 0.302
bB 0.037 0.424
bA 0.044 
Control 0.048
cB 0.017 0.057
cA 0.019 
Means having different small letters in a column are statistically 
significant (P<0.05); Mean having different capital letters in rows 
represents significant difference (P<0.05) within the days. 
 
Results of the challenge experiment on 21 day PV 
revealed significantly higher protection (67 %) in 
chickens immunized with Vaccine-II followed by 
vaccine-I (49%).  Significantly lower (P<0.05) oocyst 
count in group of chickens immunized with Vaccine-II as 
compared to Vaccine-I was recorded (Figure-I). This 
reduced oocyst count could be caused by immunity 
produced that may reduce the development of disease 
through inhibition of the growth, development and/or 
fertilization of gametes (Anwar et al., 2008). During the 
course of experiment, vaccinated chickens of both the 
groups were active and alert with normal feed and water 
intake contrary to chickens in control group that were 
dull, depressed with ruffled feathers and decreased feed 
and water intake.    
Survived and dead chickens (during experiment after 
challenge) in experimental and control groups were 
monitored for lesion scoring to assess the biological 
protection. In control group, majority of the chickens (66-
70%) demonstrated severe lesions (3.0-4.0) while 25-27 
per cent chickens showed moderate lesions (2.0). On the 
other hand, chickens immunized with Vaccine-I and 
Vaccine-II developed 74 and 69 per cent mild to 
moderated lesions (1.0-2.0), respectively.  
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Fig. 1: Oocysts per gram of droppings post challenge with Eimeria 
species (local isolates). A = Vaccine-I; B= Vaccine-II; C= Non-vaccinated 
infected Control. Bars sharing different letters on a particular day are 
statistically significant (P<0.05). 
 
Gametocytes of the two isolates used in Vaccine-I 
and Vaccine-II subject to SDS-PAGE contained  soluble 
proteins had molecular weights 27.65, 24.90, 22.75, 13.20 
kDa  and 49.23, 27.65, 24.90, 22.75, 13.20 kDa, 
respectively (details not given). Chickens immunized with 
vaccine-II contained additional gametocyte protein (49.23 
kDa) produced high level of antibodies that somehow 
prevent the formation of dityrosine bonds and their 
associated protein matrices (Wallach, 2002; Mello et al., 
2006). It can be speculated that these antibodies might 
hamper with the oocyst’s wall formation (Belli et al., 
2009). Further, the maternal antibodies produced due to 
these gametocyte proteins have the ability to protect 
hatchlings against homologous infection with Eimeria 
species (Hafeez et al., 2007; Belli et al., 2009). 
On the whole, these results demonstrated that 
vaccinal isolates (Vaccine-II) contained additional 
gametocyte protein of 49.23 kDa provided maximum 
protection to chickens in challenge experiment. It can be 
assumed that the significantly higher cross species 
protection in our previous (Hafeez et al., 2006; Ayaz et 
al., 2008) and present studies may be due to this 
additional molecular weight gametocyte protein (49.23 
kDa), which may contain the major portion of conserved 
epitopes common to the gametocytes of other Eimerian 
species (Wallach et al., 1995).  In some other studies, all 
most similar size gametocyte proteins (56 kDa) purified 
from  E. maxima protected the chickens in challenge 
experiment (Wallach et al., 1989). From these results it 
was concluded that vaccinal strain contained additional 
gametocyte proteins of high molecular weight provided 
cross protection against mixed species of genus Eimeria 
(local isolates) and has practical implications to prepare 
commercial vaccine against avian coccidiosis. Further 
studies are underway on the role of high molecular weight 
gametocyte proteins to be used in vaccine preparation 
against coccidiosis. Pak Vet J, 2012, 32(1): 77-80. 
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